🇦🇺 +61 2 9976 2467 🇨🇦 1-833 4 Cannim Mon-Fri : 09:00 - 17:00

About Us

Meet our team and discover more about Cannim
Based in Sydney, Australia, Cannim was established in 2017 to bring the benefits of medicinal cannabis to the world.

Back in 2017, Cannabis was still stigmatised and cultivation considered an art form. Built on the 3 core pillars of Safety, Science, and Scale, Cannim established an organisation that could show people that Cannabis was a real medicine, consistently develop it to pharmaceutical standards, and establish networks to reach a wide audience of needy people.

Cannim curates product from around the world and has established a network of EU GMP manufacturers, offering products and services to bring relief in many forms to people across the world.

This industry is nascent and this is only the beginning of the journey to establish Cannabis as a reputable medicine around the world. Cannim continues to create scale in its operations, giving us the ability to meet the needs of the ever-growing body of medicinal cannabis users. Cannim is pioneering the development of the category, creating new ways of administration for patients, leading research and education into the effects of cannabis on a variety of conditions, pioneering its usefulness for others, and ensuring those in need get what they need when they need it at a price that’s fair.

Executive Team

John Worton

Executive Chairman

Lachlan Cameron


Stuart Marsh

Chief Commercial Officer

Sandra de Lange

COO - Fulfilment & Compliance

Andrew Yap

Chief Financial Officer

Professor Kylie O’Brien PhD

Chief Scientific Officer



We strongly believe in the powerful network effect of teams and alliances.

We have a strong vision for the future of cannabis and we actively seek like-minded, future thinking industry pioneers to partner with. 

If your organisation shares our ambitions for this industry, get in touch with us.